EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Improved anti-breast cancer activity through structural modification of fused pyran derivatives and mechanistic investigations

K Fabitha iD, Anoop Kallingal iD, Natalia Maciejewska iD, Hiba Haneefa P T iD, Varun Thachan Kundil iD, Majed Alharbi iD, Janardhan Banothu iD

RSC Medicinal Chemistry · 2025 · 16 (8) · 3671-3696

DOI: 10.1039/d5md00161g ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von K Fabitha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Institute of Technology Calicut Kozhikode - 673601 Kerala India janardhan@nitc.ac.in +0495 228 5324. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Science and Engineering Research Board, National Institute of Technology Calicut.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel fused pyran derivatives were synthesized and evaluated for anticancer activity against MCF7 (ATCC – HTB-22, breast), A549 (ATCC – CCL-185, lung), and HCT116 (ATCC – CCL-247, colorectal) cancer cell lines.

Autor:innen und Institutionen

  • Department of Chemistry, National Institute of Technology Calicut Kozhikode - 673601 Kerala India janardhan@nitc.ac.in +0495 228 5324.
  • Department of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology Narutowicza St 11/12 80-233 Gdansk Poland.
  • Department of Biotechnology and Microbiology, School of Lifesciences, Kannur University Kannur - 670661 Kerala India.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University Jeddah 21589 Saudi Arabia.

ORCID-Profile: K Fabitha, Anoop Kallingal, Natalia Maciejewska, Hiba Haneefa P T, Varun Thachan Kundil, Majed Alharbi, Janardhan Banothu

Förderung

  • Science and Engineering Research Board
  • National Institute of Technology Calicut

Zitieren

APA

Fabitha, K., Kallingal, A., Maciejewska, N., P T, H. H., Kundil, V. T., Alharbi, M., & Banothu, J. (2025). Improved anti-breast cancer activity through structural modification of fused pyran derivatives and mechanistic investigations. RSC Medicinal Chemistry, 16(8), 3671-3696. https://doi.org/10.1039/d5md00161g

Vancouver

Fabitha K, Kallingal A, Maciejewska N, P T HH, Kundil VT, Alharbi M, et al. Improved anti-breast cancer activity through structural modification of fused pyran derivatives and mechanistic investigations. RSC Medicinal Chemistry. 2025;16(8):3671-3696. doi:10.1039/d5md00161g

BibTeX
@article{Fabitha2025,
  author = {Fabitha, K and Kallingal, Anoop and Maciejewska, Natalia and P T, Hiba Haneefa and Kundil, Varun Thachan and Alharbi, Majed and Banothu, Janardhan},
  title = {Improved anti-breast cancer activity through structural modification of fused pyran derivatives and mechanistic investigations},
  journal = {RSC Medicinal Chemistry},
  year = {2025},
  volume = {16},
  number = {8},
  pages = {3671--3696},
  doi = {10.1039/d5md00161g}
}
Kostenlos starten →